首页> 外文会议>ACS national meeting >Computational Approaches for Developing Informative Prior Distributions for Bayesian Calibration of PBPK Models
【24h】

Computational Approaches for Developing Informative Prior Distributions for Bayesian Calibration of PBPK Models

机译:用于开发PBPK模型的贝叶斯校准的信息先验分布的计算方法

获取原文

摘要

Using Bayesian statistical methods to quantify uncertainty and variability in human physiologically-based pharmacokinetic (PBPK.) model predictions for use in risk assessments requires prior distributions (priors), which characterize what is known or believed about parameters' values before observing in vivo data. Experimental in vivo data can then be used in Bayesian calibration of PBPK models to refine priors when it exist. However, when little or no in vivo data are available for calibration efforts, parameter estimates and uncertainties can be obtained from priors. In this chapter, we present approaches for specifying informative priors for chemical-specific PBPK model parameters based on information obtained from chemical structures and in vitro assays. Means and standard deviations (or coefficients of variation) for priors are derived from comparisons of predicted values from computational (e.g., QSAR) methods or in vitro assays and experimentally-determined chemical-specific values for a data set of chemicals.
机译:在风险评估中使用贝叶斯统计方法量化基于人体生理学的药代动力学(PBPK。)模型预测的不确定性和可变性时,需要先验分布(先验),以表征已知或相信的参数值,然后再观察体内数据。然后,可以在PBPK模型的贝叶斯校准中使用实验性体内数据来完善先验数据。然而,当很少或没有体内数据可用于校准工作时,可以从先验获得参数估计和不确定性。在本章中,我们将基于从化学结构和体外测定中获得的信息,介绍指定特定于化学物的PBPK模型参数的先验信息的方法。先验的均值和标准差(或变异系数)是根据计算数据(例如QSAR)方法或体外测定的预测值与化学数据集的实验确定的化学特异性值进行比较得出的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号